1-4 of 4
Jérôme Lambert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study

Open Access
Sarah Cayla, Lionel Karlin, Jerome Lambert, Anne Lazareth, Alexis Talbot, Mohamad Mohty, Florent Malard, Marie-Odile Petillon, Salomon Manier, Ibrahim Yakoub-Agha, Denis Caillot, Ingrid Lafon, Xavier Leleu, Niels Moya, Bruno Royer, Jean Marc Schiano de Colella, Gabriel Brisou, Cyrille Touzeau, Aurore Perrot, Pierre Bories, Laure Vincent, Hanane Guedon, Olivier Decaux, Benoît Ferment, Roch Houot, Steven Le Gouill, Noemie Bigot, Thierry Facon, Jill Corre, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood Advances
Blood Adv bloodadvances.2025017597.
https://doi.org/10.1182/bloodadvances.2025017597
Published: 2025
Includes: Supplemental data
Journal Articles

Enriching single-arm clinical trials with external controls: possibilities and pitfalls

Free
Clinical Trials & Observations
Jérôme Lambert, Etienne Lengliné, Raphaël Porcher, Rodolphe Thiébaut, Sarah Zohar, Sylvie Chevret
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5680–5690.
https://doi.org/10.1182/bloodadvances.2022009167
Published: 2023
Journal Articles

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study

Free
Clinical Trials & Observations
Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Maël Heiblig, Pierre-Yves Dumas, Christian Récher, Céline Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling Cheok, Raphael Itzykson, Nicolas Duployez
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4024–4034.
https://doi.org/10.1182/bloodadvances.2023010155
Published: 2023
Includes: Supplemental data
Journal Articles

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML

Free
Clinical Trials & Observations
Juliette Lambert, Jerome Lambert, Xavier Thomas, Alice Marceau-Renaut, Jean-Baptiste Micol, Aline Renneville, Emmanuelle Clappier, Sandrine Hayette, Christian Récher, Emmanuel Raffoux, Arnaud Pigneux, Celine Berthon, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Nicolas Boissel, Philippe Rousselot, Claude Preudhomme, Hervé Dombret, Nicolas Duployez
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5258–5268.
https://doi.org/10.1182/bloodadvances.2021004322
Published: 2021
Includes: Supplemental data